IO Biotech stockholders elect Nielsen and Smith as Class I directors, ratify EY as auditor

IO Biotech, Inc.

Jack B. Nielsen elected with 22,460,202 for, 938,718 withheld, 320,057 broker non-votes.
David V. Smith elected with 23,387,185 for, 11,735 withheld, 320,057 broker non-votes.
Ratification of EY as independent auditor for FY2022: 23,707,581 for, 10,261 against, 1,136 abstain, no broker non-votes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.